Effect of the PPARG2 Pro12Ala polymorphism on associations of physical activity and sedentary time with markers of insulin sensitivity in those with an elevated risk of type 2 diabetes

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Yates, Thomas ^a,b   Davies, Melanie J ^a,b   Henson, Joseph ^a,b   Edwardson, Charlotte ^a,b   Webb, David ^a,b   Bodicoat, Danielle H ^a,b   Webb, M'Balu ^c   Howard, Philip ^d   Cooper, Jackie A ^d   Humphries, Steve E ^d   Khunti, Kamlesh ^a,b   Talmud, Philippa ^d  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b National Institute for Health Research ^*  (United Kingdom)

^c UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; PROLINE; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLACK PERSON; DNA EXTRACTION; DNA MODIFICATION; FEMALE; GENE INTERACTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HIGH RISK POPULATION; HOMOZYGOTE; HUMAN; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MARKER GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PPARG2 GENE; RISK ASSESSMENT; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ACCELEROMETRY; BLOOD; DIET RESTRICTION; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MOTOR ACTIVITY; PATHOPHYSIOLOGY; RISK; STATISTICAL MODEL;

ACCELEROMETRY; AGED; BIOMARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GENE EXPRESSION; GENOTYPE; HOMOZYGOTE; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MALE; MIDDLE AGED; MOTOR ACTIVITY; POLYMORPHISM, GENETIC; PPAR GAMMA; RISK; SEDENTARY LIFESTYLE;

EID: 84929301446     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0124062     Document Type: Article

References (36)

1. Dubuquoy L, Dharancy S, Nutten S, Pettersson S, Auwerx J, Desreumauxa P. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 2002; 360: 1410-1418. PMID: 12424006
2. Deeb SS, Fajas L, Nemoto M, Pihlajamaki J, Mykkanen L, Kuusisto J, et al. A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet. 2008; 20: 284-287.
3. Gouda HN, Sagoo GS, Harding AH, Yates J, Sandhu MS, Higgins JPT. The association between the peroxisome proliferator-activated receptor-γ2 (PPARG2) Pro12Ala gene variant and type 2 diabetes mellitus: A HuGE review and meta-analysis. Am J Epidemiol. 2010; 171: 645-655. doi: 10.1093/aje/kwp450 PMID: 20179158
4. Hagberg JM, Jenkins NT, Spangenburg E. Exercise training, genetics and type 2 diabetes-related phenotypes. Acta Physiol. 2012; 205: 456-471. doi: 10.1111/j.1748-1716.2012.02455.x PMID: 22672138
5. Luan J, Browne PO, Harding AH, Halsall DJ, O'Rahilly S, Chatterjee K, et al. Evidence for gene-nutrient interaction at the PPARγ locus. Diabetes 2001; 50: 686-689. PMID: 11246892
6. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, et al. Interaction between a peroxisome proliferator-activated receptor γ gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet. 2003; 12: 2923-2929. PMID: 14506127
7. Robitaille J, Despres JP, Perusse L, Vohl MC. The PPAR-gamma P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: Results from the quebec family study. Clin Genet 2003; 63: 109-116. PMID: 12630956
8. Healy GN, Dunstan DW, Salmon J, Cerin E, Shaw JE, Zimmet PZ, et al. Objectively measured light-intensity physical activity is independently associated with 2-h plasma glucose. Diabetes Care 2007; 30: 1384-1389. PMID: 17473059
9. Wilmot EG, Edwardson CL, Achana FA, Davies MJ, Gorely T, Gray L, et al. Sedentary time in adults and the association with diabetes, cardiovascular disease and death: Systematic review and meta-analysis. Diabetologia 2012; 55: 2895-2905. doi: 10.1007/s00125-012-2677-z PMID: 22890825
10. Henson J, Yates T, Biddle SJ, Edwardson CL, Khunti K, Wilmot E, et al. Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 2013; 56: 1012-1020. doi: 10.1007/s00125-013-2845-9 PMID: 23456209
11. Cooper AR, Sebire S, Montgomery AA, Peters TJ, Sharp DJ, Fitzsimons K, et al. Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia 2012; 55: 589-599. doi: 10.1007/s00125-011-2408-x PMID: 22167127
12. Cooper AJ, Brage S, Ekelund U, Wareham NJ, Griffin SJ, Simmons RK. Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia 2014; 57: 73-82. doi: 10.1007/s00125-013-3069-8 PMID: 24196189
13. Yates T, Davies MJ, Henson J, Troughton J, Edwardson C, Gray L, et al. Walking away from type 2 diabetes: Trial protocol of a cluster randomised controlled trial evaluating a structured education programme in those at high risk of developing type 2 diabetes. BMC Fam Pract. 2012; 13: 46-2296-13-46.
14. Gray LJ, Davies MJ, Hiles S, Taub NA, Webb DR, Srinivasan BT, et al. Detection of impaired glucose regulation and/or type 2 diabetes mellitus, using primary care electronic data, in a multiethnic UK community setting. Diabetologia 2012; 55: 959-966. doi: 10.1007/s00125-011-2432-x PMID: 22231125
15. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M. Physical activity in the united states measured by accelerometer. Med Sci Sports Exerc. 2008; 40: 181-188. PMID: 18091006
16. Trost SG, McIver KL, Pate RR. Conducting accelerometer-based activity assessments in field-based research. Med Sci Sports Exerc. 2005; 37: S531-43. PMID: 16294116
17. The English Indices of Deprivation 2007: Summary. http://webarchive.nationalarchives.gov.uk/20120919132719/http://www.communities.gov.uk/documents/communities/pdf/576659.pdf
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988; 16:1215. PMID: 3344216
19. Voight BF, Kang HM, Ding J, Palmer CD, Sidore C, Chines PS, et al. The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet.2012; 8: e1002793. doi: 10.1371/journal.pgen.1002793 PMID: 22876189
20. Harrison SC, Zabaneh D, Asselbergs FW, Drenos F, Jones GT, Shah S, et al. A gene-centric study of common carotid artery remodelling. Atherosclerosis 2013; 226: 440-446. doi: 10.1016/j.atherosclerosis.2012.11.002 PMID: 23246012
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419. PMID: 3899825
22. DeFronzo RA, Matsuda M. Reduced time points to calculate the composite index. Diabetes Care 2010; 33: e93-0646. doi: 10.2337/dc10-0646 PMID: 20587713
23. Otten J, Ahren B, Olsson T. Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: A meta-analysis. Diabetologia 2014; 57: 1781-1788. doi: 10.1007/s00125-014-3285-x PMID: 24891021
24. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: Advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab. 2008; 294: E15-26. PMID: 17957034
25. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 2006; 29: 1130-1139. PMID: 16644654
26. Kilpelainen TO, Lakka TA, Laaksonen DE, Lindstrom J, Eriksson JG, Valle TT, et al. SNPs in PPARG associate with type 2 diabetes and interact with physical activity. Med Sci Sports Exerc. 2008; 40: 25-33. PMID: 18091023
27. Nelson TL, Fingerlin TE, Moss LK, Barmada MM, Ferrell RE, Norrisb JM. Association of the peroxisome proliferator-activated receptor gamma gene with type 2 diabetes mellitus varies by physical activity among non-hispanic whites from Colorado. Metabolism 2007; 56: 388-393. PMID: 17292728
28. Brito EC, Lyssenko V, Renstrom F, Berglund G, Nilsson PM, Groop L, et al. Previously associated type 2 diabetes variants may interact with physical activity to modify the risk of impaired glucose regulation and type 2 diabetes: A study of 16,003 swedish adults. Diabetes 2009; 58: 1411-1418. doi: 10.2337/db08-1623 PMID: 19324937
29. Ostergard T, Ek J, Hamid Y, Saltin B, Pedersen OB, Schmitz O. Influence of the PPAR-gamma2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects. Horm Metab Res. 2005; 37: 99-105. PMID: 15778927
30. Ruchat SM, Rankinen T, Weisnagel SJ, Rice T, Rao DC, Bergman RN, et al. Improvements in glucose homeostasis in response to regular exercise are influenced by the PPARG Pro12Ala variant: Results from the HERITAGE family study. Diabetologia 2010; 53: 679-689. doi: 10.1007/s00125-009-1630-2 PMID: 20043145
31. Weiss EP, Kulaputana O, Ghiu IA, Brandauer J, Wohn CR, Phares DA, et al. Endurance training-induced changes in the insulin response to oral glucose are associated with the peroxisome proliferator-activated receptor-γ2 Pro12Ala genotype in men but not in women. Metabolism 2005; 54: 97-102. PMID: 15562387
32. Adamo KB, Sigal RJ, Williams K, Kenny G, Prud'homme D, Tesson F. Influence of Pro12Ala peroxisome proliferator-activated receptor γ2 polymorphism on glucose response to exercise training in type 2 diabetes. Diabetologia 2005; 48: 1503-1509. PMID: 15986237
33. Kahara T, Takamura T, Hayakawa T, Nagai Y, Yamaguchi H, Katsuki T, et al. (2003) PPARγ gene polymorphism is associated with exercise-mediated changes of insulin resistance in healthy men. Metabolism 52: 209-212. PMID: 12601634
34. Yates T, Wilmot EG, Khunti K, Biddle S, Gorely T, Davies M. Stand up for your health: Is it time to rethink the physical activity paradigm? Diabetes Res Clin Pract. 2011; 93: 292-294. doi: 10.1016/j.diabres.2011.03.023 PMID: 21507499
35. Owen N, Healy GN, Matthews CE, Dunstan DW. Too much sitting: The population health science of sedentary behavior. Exerc Sport Sci Rev. 2010; 38: 105-113. doi: 10.1097/JES.0b013e3181e373a2 PMID: 20577058
36. Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, et al. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab. 2007; 92: 1502-1509. PMID: 17213274